These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 9489835

  • 1. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
    Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V.
    J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M, Vignola S, Barbano G, Sormani MP, Sabatini F, Buoncompagni A, Picco P, Pistoia V.
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [Abstract] [Full Text] [Related]

  • 3. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 4. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
    Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA.
    J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
    [Abstract] [Full Text] [Related]

  • 6. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
    Núñez-González JR, Sanabria-Vera CJ, Romero-Adrián T.
    Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
    [Abstract] [Full Text] [Related]

  • 7. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H, Kawasaki E, Miyashita T, Tanaka F, Kamachi M, Izumi Y, Huang M, Tamai M, Origuchi T, Kawakami A, Migita K, Motomura M, Yoshimura T, Eguchi K.
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [Abstract] [Full Text] [Related]

  • 8. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegård J.
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [Abstract] [Full Text] [Related]

  • 9. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
    Himmerich H, Beitinger PA, Fulda S, Wehrle R, Linseisen J, Wolfram G, Himmerich S, Gedrich K, Wetter TC, Pollmächer T.
    Arch Intern Med; 2006 Sep 18; 166(16):1739-43. PubMed ID: 16983052
    [Abstract] [Full Text] [Related]

  • 10. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
    Mizia-Stec K, Mandecki T, Zahorska-Markiewicz B, Janowska J, Szulc A, Jastrzebska-Maj E, Szymański L.
    Pol Merkur Lekarski; 2001 Jul 18; 11(61):19-25. PubMed ID: 11579824
    [Abstract] [Full Text] [Related]

  • 11. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun 18; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 12. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Jun 18; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 13. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 18; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 14. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 18; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 15. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
    Zhang D, Li J, Jiang Z, Yu B, Tang X.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1529-31. PubMed ID: 12609060
    [Abstract] [Full Text] [Related]

  • 16. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec 25; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 17. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J, Stabuc B, Rudolf Z, Galvani V, Curin-Serbec V.
    Melanoma Res; 2000 Jun 25; 10(3):253-8. PubMed ID: 10890379
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of infliximab in active SLE: a pilot study.
    Uppal SS, Hayat SJ, Raghupathy R.
    Lupus; 2009 Jul 25; 18(8):690-7. PubMed ID: 19502264
    [Abstract] [Full Text] [Related]

  • 19. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 20. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
    Tur-Kaspa I, Maor Y, Weissenberg R, Madgar I, Aderka D, Dor J, Mashiach S, Wallach D.
    J Urol; 1996 Apr 04; 155(4):1436-8. PubMed ID: 8632606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.